BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 11417997)

  • 1. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
    Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
    Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic mouse model for mammary carcinogenesis.
    Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
    Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM; Welsh J
    Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.
    Andrechek ER; Hardy WR; Laing MA; Muller WJ
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4984-9. PubMed ID: 15051890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
    Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
    Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
    Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
    Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice.
    Henry MD; Triplett AA; Oh KB; Smith GH; Wagner KU
    Oncogene; 2004 Sep; 23(41):6980-5. PubMed ID: 15286714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.
    Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schröck E; Dickson RB; Ried T
    Genes Chromosomes Cancer; 1999 Jul; 25(3):251-60. PubMed ID: 10379871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.